{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:54:51Z","timestamp":1783979691447,"version":"3.55.0"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Chronic infection with hepatitis C virus (HCV) has a long-term impact on hepatic consequences. A comprehensive evaluation of the global burden of HCV-related health outcomes can help to develop a global HCV prevention and treatment program.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We used the 2019 Global Burden of Disease (GBD) Study to comprehensively investigate burden and temporal trends in incidence, mortality and disability-adjusted life-years (DALYs) of HCV-related diseases, including liver cancer and cirrhosis and other liver diseases across 264 countries and territories from 2010 to 2019.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Globally, there were 152 225 incident cases, 141 811 deaths and approximately 2.9 million DALYs because of HCV-related liver cancer, and 551 668 incident cases, 395 022 deaths and about 12.2 million DALYs because of HCV-related cirrhosis in 2019. Worldwide, during the 2010\u20132019 period, liver cancer incidence declined, however, there was a 62% increase in cirrhosis incidence. In 2019, the Eastern Mediterranean was the region with the highest rates of incidence and mortality of both liver cancer and cirrhosis. Africa was the region with the fastest-growing trend of incidence of cirrhosis in the 2010\u20132019 period [annual percentage change (APC)\u2005=\u20052.09, 95% confidence interval (CI): 1.93\u20132.25], followed by the Western Pacific region (APC\u2005=\u20051.17, 95% CI: 1.09\u20131.22). Americas were the only region observing increased trends in liver cancer and cirrhosis mortality (APC\u2005=\u20050.70 and 0.12, respectively). We identified three patterns of temporal trends of mortality rates of liver cancer and cirrhosis in countries that reported HCV treatment rates.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Urgent measures are required for diagnosis, treatment and research on HCV-related cirrhosis at global, regional and country levels, particularly in Africa, the Western Pacific and the Eastern Mediterranean.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cej.0000000000000885","type":"journal-article","created":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T15:20:22Z","timestamp":1712157622000},"page":"512-524","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Changing global epidemiology of chronic hepatitis C virus-related outcomes from 2010 to 2019: cirrhosis is the growing burden of hepatitis C virus-related disease"],"prefix":"10.1097","volume":"33","author":[{"given":"Yen Thi-Hai","family":"Pham","sequence":"first","affiliation":[{"name":"University of Pittsburgh Medical Center Hillman Cancer Center"},{"name":"Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Q.","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng Han","family":"Ng","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren Jun Hao","family":"Tan","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiep C.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Kanazawa University Graduate School of Medicine, Kanazawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tin C.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Computer Science and Software Engineering, Auburn University, Auburn, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaideep","family":"Behari","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Pittsburgh Medical Center"},{"name":"Pittsburgh Liver Research Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Min","family":"Yuan","sequence":"additional","affiliation":[{"name":"University of Pittsburgh Medical Center Hillman Cancer Center"},{"name":"Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung N.","family":"Luu","sequence":"additional","affiliation":[{"name":"University of Pittsburgh Medical Center Hillman Cancer Center"},{"name":"Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,3,22]]},"reference":[{"key":"R1-20250527","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease Study 2015.","volume":"3","author":"Akinyemiju","year":"2017","journal-title":"JAMA Oncol"},{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S2468-1253(22)00082-6","article-title":"Progress towards elimination of viral hepatitis by 2030 in the WHO Eastern Mediterranean Region, 2019.","volume":"7","author":"Alaama","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jhep.2017.10.019","article-title":"The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: an international study.","volume":"68","author":"Alavi","year":"2018","journal-title":"J Hepatol"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S2468-1253(22)00050-4","article-title":"Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review.","volume":"7","author":"Alberts","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cmet.2023.02.003","article-title":"The global burden of metabolic disease: data from 2000 to 2019.","volume":"35","author":"Chew","year":"2023","journal-title":"Cell Metab"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"e0252072","DOI":"10.1371\/journal.pone.0252072","article-title":"Modelling future trajectories of obesity and body mass index in England.","volume":"16","author":"Cobiac","year":"2021","journal-title":"PLoS One"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41575-018-0018-5","article-title":"HCV therapy and risk of liver cancer recurrence: who to treat?","volume":"15","author":"Colombo","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"e1003198","DOI":"10.1371\/journal.pmed.1003198","article-title":"The global burden of disease attributable to high body mass index in 195 countries and territories, 1990-2017: an analysis of the Global Burden of Disease Study.","volume":"17","author":"Dai","year":"2020","journal-title":"PLoS Med"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/hep.30988","article-title":"Cure with interferon-free direct-acting antiviral is associated with increased survival in patients with hepatitis C virus-related hepatocellular carcinoma from both east and west.","volume":"71","author":"Dang","year":"2020","journal-title":"Hepatology"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"e0135645","DOI":"10.1371\/journal.pone.0135645","article-title":"Drug authorization for sofosbuvir\/ledipasvir (harvoni) for chronic HCV infection in a real-world cohort: a new barrier in the HCV care cascade.","volume":"10","author":"Do","year":"2015","journal-title":"PLoS One"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S2468-1253(22)00009-7","article-title":"Global elimination of hepatitis C: a warning from the data.","volume":"7","author":"Dusheiko","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/IJGM.S119301","article-title":"Hepatitis C in Egypt - past, present, and future.","volume":"10","author":"Elgharably","year":"2017","journal-title":"Int J Gen Med"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: Final update of the series\u2606.","volume":"73","year":"2020","journal-title":"J Hepatol"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.amepre.2011.10.026","article-title":"Obesity and severe obesity forecasts through 2030.","volume":"42","author":"Finkelstein","year":"2012","journal-title":"Am J Prev Med"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0140-6736(20)30977-6","article-title":"Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019.","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","article-title":"Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"187","DOI":"10.9745\/GHSP-D-20-00234","article-title":"Egypt\u2019s ambitious strategy to eliminate hepatitis C virus: a case study.","volume":"9","author":"Hassanin","year":"2021","journal-title":"Glob Health Sci Pract"},{"key":"R21-20250527","first-page":"265","article-title":"Drug pricing & challenges to hepatitis C treatment access.","volume":"14","author":"Henry","year":"2018","journal-title":"J Health Biomed Law"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","article-title":"Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer.","volume":"34","author":"Huang","year":"2022","journal-title":"Cell Metab"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","article-title":"Global epidemiology of cirrhosis - aetiology, trends and predictions.","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R24-20250527","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1200\/JCO.23.00757","article-title":"Antiviral therapy utilization and 10-year outcomes in resected hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma.","volume":"42","author":"Huang","year":"2024","journal-title":"J Clin Oncol"},{"key":"R25-20250527","doi-asserted-by":"crossref","first-page":"djx030","DOI":"10.1093\/jnci\/djx030","article-title":"Annual report to the nation on the status of cancer, 1975-2014, featuring survival.","volume":"109","author":"Jemal","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"R26-20250527","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection.","volume":"345","author":"Lauer","year":"2001","journal-title":"N Engl J Med"},{"key":"R27-20250527","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1200\/JCO.2010.29.1500","article-title":"Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study.","volume":"28","author":"Lee","year":"2010","journal-title":"J Clin Oncol"},{"key":"R28-20250527","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/infdis\/jis385","article-title":"Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study.","volume":"206","author":"Lee","year":"2012","journal-title":"J Infect Dis"},{"key":"R29-20250527","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1111\/liv.15357","article-title":"Comparison of primary liver cancer mortality estimates from World Health Organization, global burden disease and global cancer observatory.","volume":"42","author":"Li","year":"2022","journal-title":"Liver Int"},{"key":"R30-20250527","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1001\/jama.2013.2726","article-title":"Sustained virological response to treatment in patients with chronic hepatitis C.","volume":"309","author":"Maisonneuve","year":"2013","journal-title":"JAMA"},{"key":"R31-20250527","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41574-020-00411-y","article-title":"Nearly a decade on - trends, risk factors and policy implications in global obesity.","volume":"16","author":"Malik","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"R32-20250527","doi-asserted-by":"crossref","first-page":"17006","DOI":"10.1038\/nrdp.2017.6","article-title":"Hepatitis C virus infection.","volume":"3","author":"Manns","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R33-20250527","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41575-018-0026-5","article-title":"Management of acute HCV infection in the era of direct-acting antiviral therapy.","volume":"15","author":"Martinello","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R34-20250527","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40164-018-0109-6","article-title":"Emerging therapies in advanced hepatocellular carcinoma.","volume":"7","author":"Medavaram","year":"2018","journal-title":"Exp Hematol Oncol"},{"key":"R35-20250527","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1001\/jama.2012.144878","article-title":"Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.","volume":"308","author":"van der Meer","year":"2012","journal-title":"JAMA"},{"key":"R36-20250527","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","article-title":"Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis.","volume":"12","author":"Mokdad","year":"2014","journal-title":"BMC Med"},{"key":"R37-20250527","doi-asserted-by":"crossref","first-page":"e2245424","DOI":"10.1001\/jamanetworkopen.2022.45424","article-title":"Characteristics and treatment rate of patients with hepatitis C virus infection in the direct-acting antiviral era and during the COVID-19 pandemic in the United States.","volume":"5","author":"Nguyen","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R38-20250527","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/liv.15550","article-title":"Global treatment rate and barriers to direct-acting antiviral therapy: a systematic review and meta-analysis of 146 studies and 1 760 352 hepatitis C virus patients.","volume":"43","author":"Nguyen","year":"2023","journal-title":"Liver Int"},{"key":"R39-20250527","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/jamainternmed.2022.5699","article-title":"Association of direct-acting antiviral therapy with liver and nonliver complications and long-term mortality in patients with chronic hepatitis C.","volume":"183","author":"Ogawa","year":"2023","journal-title":"JAMA Intern Med"},{"key":"R40-20250527","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s12072-016-9717-6","article-title":"APASL consensus statements and recommendation on treatment of hepatitis C.","volume":"10","author":"Omata","year":"2016","journal-title":"Hepatol Int"},{"key":"R41-20250527","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1111\/liv.15452","article-title":"Incidence trends of acute viral hepatitis caused by four viral etiologies between 1990 and 2019 at the global, regional and national levels.","volume":"42","author":"Ouyang","year":"2022","journal-title":"Liver Int"},{"key":"R42-20250527","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/hep.31173","article-title":"Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD.","volume":"72","author":"Paik","year":"2020","journal-title":"Hepatology"},{"key":"R43-20250527","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/hep4.1634","article-title":"Direct-acting antiviral treatment use remains low among Florida Medicaid beneficiaries with chronic hepatitis C.","volume":"5","author":"Park","year":"2021","journal-title":"Hepatol Commun"},{"key":"R44-20250527","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.","volume":"2","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R45-20250527","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","article-title":"Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R46-20250527","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrgastro.2017.172","article-title":"Extrahepatic cancers and chronic HCV infection.","volume":"15","author":"Pol","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R47-20250527","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature.","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"R48-20250527","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/j.cgh.2015.08.014","article-title":"Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice.","volume":"13","author":"Singal","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R49-20250527","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1111\/liv.15347","article-title":"Global trends and the impact of chronic hepatitis B and C on disability-adjusted life years.","volume":"42","author":"Veracruz","year":"2022","journal-title":"Liver Int"},{"key":"R50-20250527","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/jvh.13663","article-title":"Global incidence and mortality of hepatitis B and hepatitis C acute infections, cirrhosis and hepatocellular carcinoma from 2010 to 2019.","volume":"29","author":"Veracruz","year":"2022","journal-title":"J Viral Hepat"},{"key":"R52-20250527","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jhep.2021.04.035","article-title":"Global burden of acute viral hepatitis and its association with socioeconomic development status, 1990-2019.","volume":"75","author":"Zeng","year":"2021","journal-title":"J Hepatol"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000885","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:00:39Z","timestamp":1748361639000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,22]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000885","relation":{},"ISSN":["0959-8278","1473-5709"],"issn-type":[{"value":"0959-8278","type":"print"},{"value":"1473-5709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,22]]}}}